Literature DB >> 7706512

Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

C S Herrington1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7706512      PMCID： PMC502251          DOI： 10.1136/jcp.48.1.1

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  58 in total

1.  Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers.

Authors:  G Riou; M G Lê; M Favre; D Jeannel; J Bourhis; G Orth
Journal:  J Natl Cancer Inst       Date:  1992-10-07       Impact factor: 13.506

2.  p53 point mutation in HPV negative human cervical carcinoma cell lines.

Authors:  T Crook; D Wrede; K H Vousden
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

3.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein.

Authors:  A Storey; N Almond; K Osborn; L Crawford
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

5.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription.

Authors:  S D Vernon; C E Hart; W C Reeves; J P Icenogle
Journal:  Virus Res       Date:  1993-02       Impact factor: 3.303

7.  Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection.

Authors:  A Spinillo; P Tenti; R Zappatore; F De Seta; E Silini; S Guaschino
Journal:  Gynecol Oncol       Date:  1993-02       Impact factor: 5.482

8.  Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

Authors:  T D Kessis; R J Slebos; W G Nelson; M B Kastan; B S Plunkett; S M Han; A T Lorincz; L Hedrick; K R Cho
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells.

Authors:  C D Woodworth; U Lichti; S Simpson; C H Evans; J A DiPaolo
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

10.  Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia.

Authors:  A E Morelli; C Sananes; G Di Paola; A Paredes; L Fainboim
Journal:  Am J Clin Pathol       Date:  1993-02       Impact factor: 2.493
View more
  19 in total

1.  Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors.

Authors:  P K Chan; M Y Chan; W W Li; D P Chan; J L Cheung; A F Cheng
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma.

Authors:  Y Shoji; M Saegusa; Y Takano; M Ohbu; I Okayasu
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  How does tobacco smoke contribute to cervical carcinogenesis?

Authors:  Philip E Castle
Journal:  J Virol       Date:  2008-06       Impact factor: 5.103

4.  Interphase cytogenetic analysis of cervical intraepithelial neoplasia.

Authors:  J Bulten; P J Poddighe; J C Robben; J H Gemmink; P C de Wilde; A G Hanselaar
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 5.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

6.  Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.

Authors:  Brian S Bowser; Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  Detection of a transforming fragment of herpes simplex virus type 2 in clinical specimens by PCR. The Canadian Women's HIV Study Group.

Authors:  G H Guibinga; F Coutlée; A Kessous; C Hankins; N Lapointe; G Richer; J Tousignant
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

9.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Cytomegalovirus occurrence in chronic periodontitis and in carcinoma of the cervix: an exploratory study.

Authors:  Shivali Surendra Rao Gaekwad; Sheela Kumar Gujjari
Journal:  J Clin Diagn Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.